
Coronavirus and Cancer Resources for Survivors
Cancer survivors have expressed concerns and questions about COVID-19, the coronavirus, and how they may be at higher risk due to their cancer history. Here are some resources about COVID-19 generally, and its impact for cancer survivors specifically. NCCS is seeking answers from public health experts on the coronavirus and its impact on cancer patients and survivors. Please leave a comment [...]

NCCS receives Cardinal Health Foundation grant to improve patient safety
The National Coalition for Cancer Survivorship was selected by the Cardinal Health Foundation as one of 42 grant recipients to fund…

NCCS updates two long-standing publications; begins offering Cancer Survival Toolbox End of Life program as a standalone
NCCS has recently updated two of its long-standing publications: one that addresses employment rights as a cancer survivor and the…

NCCS sponsors IOM study to demographic issues in quality of cancer care
NCCS, along with 11 other organizations sponsored an Institute of Medicine (IOM) consensus study: Improving the Quality of Cancer…

NCCS participates in roundtable meeting to discuss future of Health IT
NCCS was recently invited to participate in a roundtable discussion on the potential role of Health Information Technology in cancer…

NCCS applauds the Supreme Court decision upholding the Affordable Care Act
The National Coalition for Cancer Survivorship (NCCS), a national organization representing survivors of all types of cancer, commends…

Band-aids for the health law
White House officials say they are confident the Supreme Court will uphold the health-care law, but they also are preparing for a range…

Surviving cancer: It’s complicated
Cancer is complicated. And being a survivor can be complicated, too -- confounding, confronting, and confusing.
Even starting with…

US cancer survivors to rise by a third by 2022, report says
The number of Americans living with cancer will increase by nearly a third to almost 18 million by 2022, according to a report released…

ASCO Announces CancerLinQ, an Initiative to Transform Cancer Care
ASCO is embarking on CancerLinQ, a multi-phase initiative that promises to change the way cancer is understood and treated. This…

House passes FDA’s $6.4 billion fee plan for drug reviews
The $6.4 billion accord that Teva Pharmaceutical Industries Inc. (TEVA), Johnson & Johnson (JNJ) (JNJ) and other companies reached…

